RAC 2.92% $1.94 race oncology ltd

Industry news, page-975

  1. 1,522 Posts.
    lightbulb Created with Sketch. 378
    Here’s a list of the top 10 of the biggest M&A by pharma in 2022 that just came out on Fierce Pharma.

    50% to 130% premium for most companies means we are a long long way in terms of SP/MC to be at our blue sky buyout targets with SP atm.

    https://www.fiercepharma.com/pharma/top-10-ma-deals-2022
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.